AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 58 filers reported holding AMPIO PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $20,000 | -16.7% | 121,374 | +138.6% | 0.00% | – |
Q1 2022 | $24,000 | -96.4% | 50,879 | -95.6% | 0.00% | -100.0% |
Q4 2021 | $664,000 | -4.5% | 1,164,947 | +178.4% | 0.00% | 0.0% |
Q3 2021 | $695,000 | +708.1% | 418,422 | +709.1% | 0.00% | – |
Q2 2021 | $86,000 | -34.8% | 51,717 | -11.8% | 0.00% | – |
Q1 2016 | $132,000 | -33.7% | 58,628 | +2.9% | 0.00% | – |
Q4 2015 | $199,000 | +13.7% | 56,988 | -5.7% | 0.00% | – |
Q3 2015 | $175,000 | -39.2% | 60,455 | -50.2% | 0.00% | – |
Q2 2015 | $288,000 | -60.5% | 121,458 | +25.2% | 0.00% | -100.0% |
Q1 2015 | $730,000 | +138.6% | 97,006 | +8.6% | 0.00% | – |
Q4 2014 | $306,000 | +188.7% | 89,303 | +197.7% | 0.00% | – |
Q3 2014 | $106,000 | -48.5% | 30,000 | +21.9% | 0.00% | – |
Q2 2014 | $206,000 | -76.7% | 24,612 | -82.3% | 0.00% | -100.0% |
Q1 2014 | $885,000 | +727.1% | 139,390 | +873.5% | 0.00% | – |
Q3 2013 | $107,000 | – | 14,319 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CVA Family Office, LLC | 1,173,200 | $1,865,000 | 1.14% |
PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $1,387,000 | 0.82% |
Cypress Capital Management LLC (WY) | 214,575 | $341,000 | 0.30% |
Western Wealth Management, LLC | 982,350 | $1,562,000 | 0.23% |
SRS Capital Advisors, Inc. | 615,659 | $979,000 | 0.14% |
Willis Investment Counsel | 1,213,053 | $1,929,000 | 0.13% |
Harvest Investment Services, LLC | 124,423 | $197,000 | 0.10% |
Transform Wealth, LLC | 205,481 | $327,000 | 0.07% |
COURIER CAPITAL LLC | 379,973 | $604,000 | 0.07% |
BRIGHTON JONES LLC | 398,912 | $634,000 | 0.04% |